Common Dermatologic Procedures and the Associated Complications Unique to Skin of Color.
Chemexfoliation
/ adverse effects
Cosmetic Techniques
/ adverse effects
Dermatologic Surgical Procedures
/ adverse effects
Dry Needling
/ adverse effects
Humans
Hyperpigmentation
/ etiology
Hypopigmentation
/ etiology
Keloid
/ etiology
Laser Therapy
/ adverse effects
Postoperative Complications
Risk Factors
Skin Pigmentation
Surgical Wound Infection
/ etiology
Journal
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
ISSN: 1524-4725
Titre abrégé: Dermatol Surg
Pays: United States
ID NLM: 9504371
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
18
8
2021
Statut:
ppublish
Résumé
The skin of color (SOC) population in the United States continues to grow, and these patients are undergoing various cosmetic and surgical procedures at increasing rates. There is a paucity of data on the potential complications associated with surgical and cosmetic procedures in this patient population. We aim to educate dermatologic surgeons and clinicians on surgical and cosmetic procedures in patients of color and increase awareness of the potential complications unique to this patient population. A thorough PubMed literature search was performed to conduct this review. There are a number of complications in SOC that require special attention, including keloids, postoperative infections, postinflammatory hyperpigmentation, and hypopigmentation. There are also various precautions to consider when performing cosmetic procedures, such as neurotoxin and filler injections, laser therapy, microneedling, and chemical peels. Dermatologists should be aware of the potential cosmetic and surgical complications of this growing patient population to provide optimal evidence-based medical care.
Sections du résumé
BACKGROUND
The skin of color (SOC) population in the United States continues to grow, and these patients are undergoing various cosmetic and surgical procedures at increasing rates. There is a paucity of data on the potential complications associated with surgical and cosmetic procedures in this patient population.
OBJECTIVE
We aim to educate dermatologic surgeons and clinicians on surgical and cosmetic procedures in patients of color and increase awareness of the potential complications unique to this patient population.
MATERIALS AND METHODS
A thorough PubMed literature search was performed to conduct this review.
RESULTS
There are a number of complications in SOC that require special attention, including keloids, postoperative infections, postinflammatory hyperpigmentation, and hypopigmentation. There are also various precautions to consider when performing cosmetic procedures, such as neurotoxin and filler injections, laser therapy, microneedling, and chemical peels.
CONCLUSION
Dermatologists should be aware of the potential cosmetic and surgical complications of this growing patient population to provide optimal evidence-based medical care.
Identifiants
pubmed: 34328287
doi: 10.1097/DSS.0000000000002813
pii: 00042728-202103000-00012
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
355-359Informations de copyright
Copyright © 2020 by the American Society for Dermatologic Surgery, Inc. Published by Wolters Kluwer Health, Inc. All rights reserved.
Références
Ortman JM, Guarneri CE. United States Population Projections: 2000 to 2050. Available from: https://www.census.gov/population/projections/files/analytical-document09.pdf. Accessed May 15, 2020.
Halder RM, Nootheti PK. Ethnic skin disorders overview. J Am Acad Dermatol 2003;48(6 Suppl):S143–8.
Nijhawan RI, Jacob SE, Woolery-Lloyd H. Skin of color education in dermatology residency programs: does residency training reflect the changing demographics of the United States?. J Am Acad Dermatol 2008;59:615–8.
Surgeons, A.S.o.P. 2018. Plastic Surgery Statistics Report. Available from: https://www.plasticsurgery.org/news/plastic-surgery-statistics. Accessed May 15, 2020.
Alexis AF, Few J, Callender VD, Grimes P, et al. Myths and knowledge gaps in the aesthetic treatment of patients with skin of color. J Drugs Dermatol 2019;18:616–22.
Alexis AF. Lasers and light-based therapies in ethnic skin: treatment options and recommendations for Fitzpatrick skin types V and VI. Br J Dermatol 2013;169(Suppl 3):91–7.
Ross EV, Cooke LM, Timko AL, Overstreet KA, et al. Treatment of pseudofolliculitis barbae in skin types IV, V, and VI with a long-pulsed neodymium:yttrium aluminum garnet laser. J Am Acad Dermatol 2002;47:263–70.
Alam M. What devices to use or not use in skin of color. Semin Cutan Med Surg 2016;35:218–22.
Cheyasak N, Manuskiatti W, Maneeprasopchoke P, Wanitphakdeedecha R. Topical corticosteroids minimise the risk of postinflammatory hyper-pigmentation after ablative fractional CO2 laser resurfacing in Asians. Acta Derm Venereol 2015;95:201–5.
Khandpur S, Sharma VK. Assessment of efficacy of the 595-nm pulsed dye laser in the treatment of facial port-wine stains in Indian patients. Dermatol Surg 2016;42:717–26.
West TB, Alster TS. Effect of pretreatment on the incidence of hyperpigmentation following cutaneous CO2 laser resurfacing. Dermatol Surg 1999;25:15–7.
Alajlan AM, Alsuwaidan SN. Acne scars in ethnic skin treated with both non-ablative fractional 1,550 nm and ablative fractional CO2 lasers: comparative retrospective analysis with recommended guidelines. Lasers Surg Med 2011;43:787–91.
Wanitphakdeedecha R, Phuardchantuk R, Manuskiatti W. The use of sunscreen starting on the first day after ablative fractional skin resurfacing. J Eur Acad Dermatol Venereol 2014;28:1522–8.
Cohen BE, Elbuluk N. Microneedling in skin of color: a review of uses and efficacy. J Am Acad Dermatol 2016;74:348–55.
Al Qarqaz F, Al-Yousef A. Skin microneedling for acne scars associated with pigmentation in patients with dark skin. J Cosmet Dermatol 2018;17:390–5.
Dogra S, Yadav S, Sarangal R. Microneedling for acne scars in Asian skin type: an effective low cost treatment modality. J Cosmet Dermatol 2014;13:180–7.
Vemula S, Maymone MBC, Secemsky EA, Widjajahakim R, et al. Assessing the safety of superficial chemical peels in darker skin: a retrospective study. J Am Acad Dermatol 2018;79:508–13.e2.
Salam A, Dadzie OE, Galadari H. Chemical peeling in ethnic skin: an update. Br J Dermatol 2013;169(Suppl 3):82–90.
Taylor SC, Callender VD, Albright CD, Coleman J, et al. AbobotulinumtoxinA for reduction of glabellar lines in patients with skin of color: post hoc analysis of pooled clinical trial data. Dermatol Surg 2012;38:1804–11.
Kane MA, Brandt F, Rohrich RJ, Narins RS, et al. Evaluation of variable-dose treatment with a new U.S. botulinum toxin type A (Dysport) for correction of moderate to severe glabellar lines: results from a phase III, randomized, double-blind, placebo-controlled study. Plast Reconstr Surg 2009;124:1619–29.
Funt D, Pavicic T. Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol 2013;6:295–316.
Taylor SC, Downie JB, Shamban A, Few J, et al. Lip and perioral enhancement with hyaluronic acid dermal fillers in individuals with skin of color. Dermatol Surg 2019;45:959–67.
Hamilton TK, Burgess CM. Considerations for the use of injectable poly-L-lactic acid in people of color. J Drugs Dermatol 2010;9:451–6.
Marmur ES, Taylor SC, Grimes PE, Boyd CM, et al. Six-month safety results of calcium hydroxylapatite for treatment of nasolabial folds in Fitzpatrick skin types IV to VI. Dermatol Surg 2009;35(Suppl 2):1641–5.
Battie C, Gohara M, Verschoore M, Roberts W. Skin cancer in skin of color: an update on current facts, trends, and misconceptions. J Drugs Dermatol 2013;12:194–8.
Zell JA, Cinar P, Mobasher M, Ziogas A, et al. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol 2008;26:66–75.
Higgins S, Nazemi A, Chow M, Wysong A. Review of nonmelanoma skin cancer in African Americans, Hispanics, and Asians. Dermatol Surg 2018;44:903–10.
Jones NA, Jungmiwha B. The Two or More Races Population: 2010. 2010 Census Briefs. U.S. Department of Commerce. Economics and Statistics Administration: U.S. Census Bureau, 2012. pp. 23.
Ruiz-Maldonado R, Orozco-Covarrubias ML. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg 1997;16:36–43.
Vachiramon V, Thadanipon K. Postinflammatory hypopigmentation. Clin Exp Dermatol 2011;36:708–14.
Friedman SJ, Butler DF, Pittelkow MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature. J Am Acad Dermatol 1988;19:537–41.
Salvatierra AR, Alweis R. Permanent hypopigmentation after triamcinolone injection for tennis elbow. J Community Hosp Intern Med Perspect 2016;6:31814.
Dhawan AK, Bisherwal K, Grover C, Tanveer N. Linear leucoderma following intralesional steroid: a report of three cases. J Cutan Aesthet Surg 2015;8:117–9.
Tracy RP. The five cardinal signs of inflammation: calor, dolor, rubor, tumor… and penuria (Apologies to Aulus Cornelius Celsus, De medicina, c. A.D. 25). J Gerontol Ser A 2006;61:1051–2.
Prevention, C.f.D.C.a. National Diabetes Statistics Report, 2017. 2017. Available from: https://www.cdc.gov/diabetes/data/statistics/statistics-report.html. Accessed April 1, 2020.
Dixon AJ, Dixon MP, Dixon JB. Prospective study of skin surgery in patients with and without known diabetes. Dermatol Surg 2009;35:1035–40.
Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity among adults and youth: United States, 2015-2016. NCHS Data Brief 2017;288:1–8.
Loffler H, Aramaki JU, Effendy I. The influence of body mass index on skin susceptibility to sodium lauryl sulphate. Skin Res Technol 2002;8:19–22.
Taylor SC, Barbosa V, Burgess C, Heath C, et al. Hair and scalp disorders in adult and pediatric patients with skin of color. Cutis 2017;100:31–5.
Alexander JW, Solomkin JS, Edwards MJ. Updated recommendations for control of surgical site infections. Ann Surg 2011;253:1082–93.
Lefebvre A, Saliou P, Lucet JC, Mimoz O, et al. Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials. J Hosp Infect 2015;91:100–8.
Brooks Carthon JM JO, Sloane D, Kutney-Lee A. Variations in postoperative complications according to race, ethnicity, and sex in older adults. J Am Geriatr Soc 2013;61:1499–507.
Zaidi Z. Skin of colour: characteristics and disease. J Pak Med Assoc 2017;67:292–9.
Awosika O, Burgess CM, Grimes PE. Considerations when treating cosmetic concerns in men of color. Dermatol Surg 2017;43(Suppl 2):S140–s150.
Lee HJ, Jang YJ. Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci 2018;19:711.
Ud-Din S, Bayat A. Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature. Br J Dermatol 2013;169(Suppl 3):71–81.
Darji K, Varade R, West D, Armbrecht ES, et al. Psychosocial impact of postinflammatory hyperpigmentation in patients with acne vulgaris. J Clin Aesthet Dermatol 2017;10:18–23.
Halder RM, Grimes PE, McLaurin CI, Kress MA, et al. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis 1983;32:388–90.
Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, et al. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol 2017;77:591–605.
Buchanan Lunsford N, Berktold J, Holman DM, Stein K, et al. Skin cancer knowledge, awareness, beliefs and preventive behaviors among black and Hispanic men and women. Prev Med Rep 2018;12:203–9.
Lee SJ, Ahn GR, Kwon HJ, Park KY, et al. Case series of post-purpuric darkness on the periorbital area after aesthetic surgery. Dermatol Ther 2019;32:e12922.
Few JW. Rejuvenation of the African American periorbital area: dynamic considerations. Semin Plast Surg 2009;23:198–206.
Kuroki LM, Mullen MM, Massad LS, Wu N, et al. Wound complication rates after staples or suture for midline vertical skin closure in obese women: a randomized controlled trial. Obstet Gynecol 2017;130:91–9.